Primary Record
Cinerubine B
- In stock
- 7,215 g
- Purity
- 99.5 %
- CAS
- 35906-51-5
Compound Identifiers & Properties
- CAS
- 35906-51-5
- PubChem CID
- 409071
- SMILES
- CCC1(CC(C2=C(C3=C(C=C2C1C(=O)OC)C(=O)C4=C(C=CC(=C4C3=O)O)O)O)OC5CC(C(C(O5)C)OC6CC7C(C(O6)C)OC8C(O7)CC(=O)C(O8)C)N(C)C)O
- Canonical SMILES
- CCC1(O)CC(OC2CC(N(C)C)C(OC3CC4OC5CC(=O)C(C)OC5OC4C(C)O3)C(C)O2)c2c(cc3c(c2O)C(=O)c2c(O)ccc(O)c2C3=O)C1C(=O)OC
Names & Synonyms
- Cinerubine B
- Cinerubin B
- Spartanamicin A
- Tauromycetin-III
- Tavromycetin III
- CINERUBIN B HCL
- Antibiotic MA 144B2
- Cinerubin B hydrochloride
- Cinerubine B, hydrochloride
- Neuro_000116
- AC1L8W39
- CHEMBL1975340
- SCHEMBL31237197
- NSC 18335
- C42H51NO16
- MA144 B2
- NSC18335
- NSC62490
- CID409071
- NSC 62490
- NSC-18335
- NSC-62490
- NSC243023
- C42-H51-N-O16
- BS-1316
- CCG-102449
- NSC-243023
- 35906-51-5
- Cinerubin-B; Ryemycin-B1; 1-Hydroxyaclacinomycin B; Tavromycetin-III; Tauromycetin-III;
- 1-Naphthacenecarboxylic acid, 4-[[[2''',3''-anhydro]-O-3,6-dideoxy-.alpha.-L-erythro-hexopyranos-4-ulos-1-yl-(1.fwdarw.4)-O-2,6-dideoxy-.alpha.-L-lyxo-hexopyranosyl-(1.fwdarw.4)-2,3,6-trideoxy-3-(dimethylamino)-.alpha.-L-lyxo-hexopyranosyl]oxy]-2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7,10-tetrahydroxy-6,11-dioxo-, methyl ester, [1R-(1.alpha.,2.beta.,4.beta.)]-
- 1-Naphthacenecarboxylic acid,3''-anhydro)-O-3,6-dideoxy-.alpha.-L-erythro-hexopyranos-4-ulos-1-yl-(1.fwdarw.4)-O-2,6-dideoxy-.alpha.-L-lyxo-hexopyranosyl-(1.fwdarw.4)-2,3,6-trideoxy-3-(dimethylamino)-.alpha.-L-lyxo-hexopyranosyl]oxy]-2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7,10-tetrahydroxy-6,11-dioxo-, methyl ester, [1R-(1.alpha.,2.beta.,4.beta.)]-
- 1-Naphthacenecarboxylic acid,3''-anhydro)-O-3,6-dideoxy-.alpha.-L-erythro-hexopyranos-4-uloslyl-(1.fwdarw.4)-O-2,6-dideoxy-.alpha.-L-lyxo-hexopyranosyl-(1.fwdarw.4)-2,3,6-trideoxy-3-(dimethylamino)-.alpha.-L-lyxo-hexopyranosyl]oxy]-2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7,10-tetrahydroxy-6,11-dioxo-, methyl ester, [1R-(1.alpha.,2.beta.,4.beta.)]-
- 1-Naphthacenecarboxylic acid,3''-anhydro]-O-3,6-dideoxy-.alpha.-L-erythro-hexopyranos-4-ulos-1-yl-(1.fwdarw.4)-O-2,6-dideoxy-.alpha.-L-lyxo-hexopyranosyl-(1.fwdarw.4)-2,3,6-trideoxy-3-(dimethylamino)-.alpha.-L-lyxo-hexopyranosyl]oxy]-2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7,10-tetrahydroxy-6,11-dioxo-, methyl ester,[1R-(1.alpha.,2.beta.,4.beta.)]-
- 1-Naphthacenecarboxylic acid,3''-anhydro]-O-3,6-dideoxy-.alpha.-L-erythro-hexopyranos-4-uloslyl-(1.fwdarw.4)-O-2,6-dideoxy-.alpha.-L-lyxo-hexopyranosyl-(1.fwdarw.4)-2,3,6-trideoxy-3-(dimethylamino)-.alpha.-L-lyxo-hexopyranosyl]oxy]-2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7,10-tetrahydroxy-6,11-dioxo-, methyl ester,[1R-(1.alpha.,2.beta.,4.beta.)]-
- methyl 4-[4-(dimethylamino)-5-[(5,14-dimethyl-6-oxo-2,4,9,13-tetraoxatricyclo[8.4.0.03,8]tetradecan-12-yl)oxy]-6-methyloxan-2-yl]oxy-2-ethyl-2,5,7,10-tetrahydroxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylate